Gemini Labs Llc patents expiration
1. Prandin patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6677358 | GEMINI LABS LLC | NIDDM regimen |
Jun, 2018
(5 years ago) | |
Drugs and Companies using REPAGLINIDE ingredient
Market Authorisation Date: 22 December, 1997
Treatment: Patented method of using repaglinide in combination with metformin as indicated for improving glycemic control in adults with type 2 diabetes mellitus
Dosage: TABLET;ORAL
How can I launch a generic of PRANDIN before it's drug patent expiration?
More Information on Dosage
PRANDIN family patents
